(NASDAQ: CNVS ) distributes over 71,000 premium films, series, and podcasts. Engaging over 150 million unique monthly users, ...

AMSBIO’s CancerSeq™ FFPE tissues provide pre-screened tumour samples validated for single nucleotide polymorphisms (SNPs), ...

As of Nov. 18, 2024, three stocks in the communication services sector could be flashing a real warning to investors who ...

Q2 2025 Earnings Call Transcript November 14, 2024 Operator: Good day, everyone. Welcome to Cineverse’s Second Quarter Fiscal 2025 Financial Results Conference Call. My name is Mikaya [ph] and I will ...

In recent trading, Cineverse Corp (CNVS) stock price has shown some volatility, fluctuating 17.22% over the last five trades and 67.54% over the past 30 trades. This represents a notable shift from ...

PeCan-Seq enables sensitive, non-invasive ctDNA analysis for pediatric cancers, with high accuracy for hematologic ...

Benchmark raised the firm’s price target on Cineverse (CNVS) to $10 from $9 and keeps a Speculative Buy rating on the shares. Cineverse ...

Cineverse Corp (CNVS) reports impressive revenue growth and outlines future strategies amid the success of "Terrifier 3".

Cineverse Corp. ( (CNVS) ) has released its Q2 earnings. Here is a breakdown of the information Cineverse Corp. presented to its investors.

Bio-Techne Corporation today announced its lineup of presentations and activities for the Association for Molecular Pathology (AMP) 2024 Annual Meeting & Expo, taking place November 19-23 in Vancouver ...

Analysts are estimating that Cineverse will report an earnings per share (EPS) of $-0.08. Cineverse bulls will hope to hear ...